Rossari Biotech Q2 Results Review - Weak Raw Material Prices Led To Tepid Earnings Growth: Yes Securities

Rossari Biotech's reported operating profits at Rs 636 million (+12% YoY; +10% QoQ).

<div class="paragraphs"><p>Chemical solution sits in a conical flask inside a lab. (Source: Freepik)</p></div>
Chemical solution sits in a conical flask inside a lab. (Source: Freepik)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More